Titre:
  • Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients.
Auteur:Chalhoub, Hussein; Tunney, Michael; Elborn, Stuart J.S.; Vergison, Anne; Denis, Olivier; Plésiat, Patrick; Kahl, Barbara C; Van Bambeke, Françoise; Tulkens, Paul M.
Informations sur la publication:Journal of antimicrobial chemotherapy, 70, 5, page (1596-1598), dku551
Statut de publication:Publié, 2014
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:ESBLs
P. aeruginosa
carbapenemases
extended-spectrum β-lactamases
β-lactamase inhibition
MeSH keywords:Anti-Bacterial Agents -- pharmacology
Azabicyclo Compounds -- pharmacology
Ceftazidime -- pharmacology
Cystic Fibrosis -- complications
Humans
Microbial Sensitivity Tests
Pseudomonas Infections -- microbiology
Pseudomonas aeruginosa -- drug effects -- isolation & purification
beta-Lactam Resistance -- drug effects
beta-Lactamase Inhibitors -- pharmacology
Langue:Anglais
Identificateurs:urn:issn:0305-7453
info:doi/10.1093/jac/dku551
info:pii/dku551
info:scp/84929761996
info:pmid/25587996